The polymorphisms Asn130Asp and Val174Ala in OATP1B1 and the CYP2C9 allele *3 independently affect torsemide pharmacokinetics and pharmacodynamics.
Clin Pharmacol Ther. 2008 Jun;83(6):815-7. doi: 10.1038/sj.clpt.6100404. Epub 2007 Nov 14.
Clin Pharmacol Ther. 2008.
PMID: 18043684
No abstract available.